OrsoBio Funding & Investors

Palo Alto, CA

OrsoBio is a clinical-stage biopharmaceutical company that creates therapies for patients suffering from severe metabolic disorders such as diabetes, severe dyslipidemia, lipodystrophies, and others. OrsoBio is committed to restoring energy homeostasis in patients with severe metabolic disorders, in some cases, by targeting pathways relevant to maintaining energy balance. OrsoBio revolutionizes the treatment of these disorders by addressing the underlying cause.